How does the type of delivery affect pelvic floor structure? MRI parameter-based anatomical study

Şenkaya, Ayşe Rabia; Ismailoglu, Eren; Arı, Sabahattin Anıl; Karaca, İbrahim

doi:10.5603/gp.a2022.0140

Cited by 4 publications

(9 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Eight studies investigated the effect of SARS‐CoV‐2 infection on AMH levels 26–36 . Ten studies investigated the possible effect of COVID‐19 vaccination on AMH levels 16,34–42 . Six studies used m‐RNA vaccines, one used the Russian GAM‐COVID vaccine, two studies used CoronaVacc, and two did not report the type of vaccines used.…”

Section: Resultsmentioning

confidence: 99%

“…The 18 included studies were published between 2021 and 2023 and were conducted in different countries, including the USA ( n = 3), China ( n = 2), Russia ( n = 2), Turkey ( n = 5), Israel ( n = 3), Czech ( n = 2) and Spain ( n = 1). Eight studies investigated the effect of SARS‐CoV‐2 infection on AMH levels 26–36 . Ten studies investigated the possible effect of COVID‐19 vaccination on AMH levels 16,34–42 .…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The effect of COVID‐19 and COVID‐19 vaccination on serum anti‐Mullerian hormone: A systematic review and meta‐analysis

Ghaemi,

Hantoushzadeh,

Shafiee

et al. 2024

Immunity Inflam & Disease

View full text Add to dashboard Cite

ObjectiveThe current study aims to evaluate the impact of COVID‐19 infection and vaccination on ovarian reserve by detecting the anti‐Mullerian hormone (AMH) level.MethodPubMed, Embase, Web of Science, and Scopus has been searched for studies assessing the effect of COVID‐19 infection and/or vaccination on AMH levels up to February 27, 2023. Based on PRISMA 2020 statement criteria, a systematic review and meta‐analysis of included studies were performed. The studies' quality was assessed by the National Institute of Health (NIH) quality assessment tool. The standardized mean difference (MD) of the AMH level was used and the quantitative values of each study were pooled separately by using a random effect model.ResultsOut of 246 studies screened, 18 were included in the systematic review and 14 in the meta‐analysis. Included studies were published between 2021 and 2022 and were conducted in different countries, including the USA (n = 3), China (n = 2), Russia (n = 2), Turkey (n = 5), Israel (n = 3), Czech (n = 2), and Spain (n = 1). Eight studies investigated the effect of SARS‐CoV‐2 infection on AMH levels, and ten studies investigated the possible effect of COVID‐19 vaccination on AMH levels. The pooled analysis showed a statistically significant decrease in AMH levels after COVID‐19 infection (SMD: −0.24; 95% CI: −0.36 to −0.11; I2 = 0%; p = .0003). Vaccination analysis showed a nonstatistically significant change in AMH levels after COVID‐19 vaccination (SMD: −0.11; 95% CI: −0.25 to 0.04; I2 = 35%; p = .14).ConclusionCOVID‐19 infection can result in ovarian reserve injury by reducing the AMH level but getting vaccinated against COVID‐19 has no impact on the AMH level.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

The effect of COVID‐19 and COVID‐19 vaccination on serum anti‐Mullerian hormone: A systematic review and meta‐analysis

Ghaemi,

Hantoushzadeh,

Shafiee

et al. 2024

Immunity Inflam & Disease

View full text Add to dashboard Cite

show abstract

“…The association between SARS-CoV-2 vaccination and ovarian reserve parameters was investigated in twelve studies summarized in Table 2 [143][144][145][146][147][148][149][150][151][152][153][154].…”

Section: Sars-cov-2 Vaccination and Female Reproductive Systemmentioning

confidence: 99%

“…Four studies [143][144][145][146][147][148] showed no significant shift in AMH and AFC levels following vaccination. However, one prospective study described a significant decrease in serum AMH levels at months 3 or 6 of follow-up compared to pre-vaccination.…”

Section: Sars-cov-2 Vaccination and Female Reproductive Systemmentioning

confidence: 99%

“…Eight reports [143][144][145][150][151][152][153][154] focused on the population undergoing assisted reproduction treatment and demonstrated no harmful impact of the SARS-CoV-2 vaccine on ovarian reserves during assisted reproduction cycles. One of the prospective studies showed that regardless of the type of vaccine, there is no significant adverse effect on ovarian function in patients treated with assisted reproduction therapy [154].…”

Section: Sars-cov-2 Vaccination and Female Reproductive Systemmentioning

confidence: 99%

See 1 more Smart Citation

SARS-CoV-2 Vaccines-Related Endocrine Disorders: An Updated Narrative Review

Ishay,

Oleinikov,

Shacham

2024

Preprint

View full text Add to dashboard Cite

The emergence of the COVID-19 pandemic has led to the rapid and worldwide devel-opment and investigation of multiple vaccines. While most side effects of these vaccines are mild and transient, potentially severe adverse events may occur and involve the endocrine system. This narrative review aims to explore the current knowledge on potential endocrine adverse effects following COVID-19 vaccination, with thyroid disorders being the most common. Data about pi-tuitary, adrenal, diabetes, and gonadal events will also be reviewed. This review also provides a comprehensive understanding of the pathogenesis of endocrine disorders associated with SARS-CoV-2 vaccines. A PubMed/MEDLINE, Embase database (Elsevier), and Google Scholar research were performed. Case reports case series, original studies, and reviews written in English and published online up to 31 August 2023 were selected and reviewed. Data on endocrine adverse events of SARS-CoV-2 vaccines is accumulating. However, their causal relationship with COVID-19 vaccines is not strong enough to make a definite conclusion, and further studies are needed to clarify the pathogenesis mechanisms of endocrine disorders linked to COVID-19 vac-cines.

show abstract

Comprehensive evaluation of the effect of inactivated SARS‐CoV‐2 vaccination on female fertility: A retrospective cohort study

Ba,

Yang,

Zhu

et al. 2023

Journal of Medical Virology

View full text Add to dashboard Cite

Fear of possible negative effects of coronavirus disease 2019 (COVID‐19) vaccine on fertility is the main reason for vaccine hesitancy among the public especially women of childbearing age. Despite the high coverage of COVID‐19 vaccination in China, more scientific evidence is still needed to address their concerns and guide fertility counseling and management in the future. Herein, we performed a retrospective cohort study at a single large center for reproductive medicine in China between August 2020 and May 2023. Patients aged 20–42 years with no history of laboratory‐confirmed COVID‐19 were included and categorized into different groups according to their vaccination status. The serum sex hormone levels, anti‐Müllerian hormone concentrations, embryo quality, and pregnancy outcomes were evaluated and compared among them. We found there were no significant differences in the concentrations of follicle‐stimulating hormone, luteinizing hormone and progesterone between the unvaccinated, first‐dose, second‐dose, and booster vaccinated groups. However, the estradiol showed a highly significant increase in the one‐dose vaccinated group compared with its levels in other groups. Among unvaccinated and either vaccinated patients, anti‐Müllerian hormone levels were comparable (p = 0.139). The number of oocytes retrieved, fertilization rate and good‐quality embryo rate were all similar between each group of in vitro fertilization and intracytoplasmic sperm injection. No significant differences were observed regarding other laboratory parameters. Moreover, the vaccination status of infertile couples did not exert any adverse effect on the pregnancy outcomes in all assisted reproductive technologies cycles. In short, we comprehensively evaluated the reproductive safety of inactivated severe acute respiratory syndrome coronavirus 2 vaccine and found any dose of vaccination wouldn't negatively affect female fertility parameters such as sex hormone levels and ovarian reserve. Moreover, this is the first study to complete the live birth follow‐up of the cohort after receiving inactivated severe acute respiratory syndrome coronavirus 2 vaccine, further dispelling the misconception and providing reassurance for decision‐making by clinicians.

show abstract

How does the type of delivery affect pelvic floor structure? MRI parameter-based anatomical study

Abstract: This article has been peer reviewed and published immediately upon acceptance.It is an open access article, which means that it can be downloaded, printed, and distributed freely, provided the work is properly cited. Articles in "Ginekologia Polska" are listed in PubMed.

Cited by 4 publications

References 24 publications

The effect of COVID‐19 and COVID‐19 vaccination on serum anti‐Mullerian hormone: A systematic review and meta‐analysis

The effect of COVID‐19 and COVID‐19 vaccination on serum anti‐Mullerian hormone: A systematic review and meta‐analysis

SARS-CoV-2 Vaccines-Related Endocrine Disorders: An Updated Narrative Review

Comprehensive evaluation of the effect of inactivated SARS‐CoV‐2 vaccination on female fertility: A retrospective cohort study

Contact Info

Product

Resources

About